Kaplan Fox probes Cellebrite over securities law violations
Alpha Vantage · The National Law Review · · AI-summarised by FinFlash
Kaplan Fox & Kilsheimer LLP is investigating Cellebrite DI Ltd. (NASDAQ: CLBT) for potential securities law violations after the stock fell 29%. The probe follows Cellebrite's August 13, 2026 second-quarter report, which missed Annual Recurring Revenue projections, cut full-year guidance and included an abrupt CEO change. The firm seeks investors who suffered losses.
Understand the context
Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.